NinePoint Medical Seals $34M Series B Funding Round
March 21, 2014
NinePoint Medical, a developer of medical devices for advanced optical imaging, has completed a $34 million Series B financing round led by Corning Incorporated, with participation from founding investors Third Rock Ventures and Prospect Venture Partners. Proceeds from the financing will support the ongoing commercial launch of the company's NvisionVLE Imaging System in the U.S., as well as development of its expanded product offering. The NvisionVLE Imaging System enables physicians and pathologists to endoscopically view real-time, high-resolution, cross sectional images of organs and tissues up to 3mm deep at better than 10 micron resolution. NinePoint, which last raised a $33 million Series A round at a valuation of $47 million in 2010, will add Corning's Curt Weinstein to its Board as part of the deal.